Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study

Hao-ying Dou; Yuan-yuan Wang; Nan Yang; Ming-li Heng; Xuan Zhou; Huai-en Bu; Fang Xu; Tie-niu Zhao; He Huang; Hong-wu Wang

doi:10.1007/s11655-015-2290-3

Your Location：

Home >

Browse articles >

Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study

Updated：2021-08-27

- Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study
- Chinese Journal of Integrative Medicine Vol. 23, Issue 6, Pages: 415-424(2017)
- Affiliations：
  
  1. Department of Nursing, Tianjin University of Traditional Chinese Medicine,Tianjin,China
  2. Department of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine,Tianjin,China
  3. Department of Biochemical Engineering, School of Chemical Engineering and Technology, Key Laboratory of Systems Bioengineering, Ministry of Education, Tianjin University,Tianjin,China
- Author bio：
- Funds：
  
  Supported by the Project of Science and Technology Development of Tianjin Municipality, China (No. 033113211), the Key Cultivated Academic Construction Project of State Administrative Bureau for Prophylactic Medicine of Traditional Chinese Medicine, China (No. 2012)
- DOI：10.1007/s11655-015-2290-3
  CLC：
- Published：2017，
  
  Published Online：26 February 2016，
Scan for full text
Dou, Hy., Wang, Yy., Yang, N. et al. Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study., Chin. J. Integr. Med. 23, 415–424 (2017). https://doi.org/10.1007/s11655-015-2290-3

Hao-ying Dou, Yuan-yuan Wang, Nan Yang, et al. Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study. [J]. Chinese Journal of Integrative Medicine 23(6):415-424(2017)
Dou, Hy., Wang, Yy., Yang, N. et al. Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study., Chin. J. Integr. Med. 23, 415–424 (2017). https://doi.org/10.1007/s11655-015-2290-3 DOI：

Hao-ying Dou, Yuan-yuan Wang, Nan Yang, et al. Association between genetic variants and characteristic symptoms of type 2 diabetes: A matched case-control study. [J]. Chinese Journal of Integrative Medicine 23(6):415-424(2017) DOI： 10.1007/s11655-015-2290-3.

摘要

To examine the association of genetic variants with characteristic symptoms of type 2 diabetes mellitus (T2DM). A matched case-control study was performed to investigate the association between common variants in four genes (CDKAL1

GLIS3

GRK5

and TCF7L2) and symptoms of T2DM. Symptoms were examined with questionnaire for 710 subjects. Genomic DNA was extracted from peripheral blood mononuclear cell by salting-out procedure. Genotyping was carried out by direct sequencing of the unpurified polymerase chain reaction products. Most of the T2DM patients pressented characteristic symptoms

such as feeling weak in limbs (P =0.0057)

hand tremor (P =0.0208)

bradymasesis (P =0.0234)

and polyuria (P =0.0051). Some of the T2DM patients shared characteristic symptoms

such as desire for cold drinks (P =0.0304)

polyphagia (P =0.0051)

and furred tongue (P =0.028). The impaired glucose regulation (IGR) cases took only one characteristic symptom of frequent micturition (P =0.0422). GLIS3 rs7034200 and GRK5 rs10886471 were significantly associated with increased T2DM risk (GLIS3 rs7034200 under dominant model: P=0.0307; GRK5 rs10886471 under recessive model: P=0.0092). However

only the rs10886471 polymorphism in GRK5 showed a significant effect on both differentiated symptoms and T2DM risk. The C-allele was involved in both dampness-heat encumbering Pi (Spleen) syndrome (P =0.047) and qi-yin deficiency syndrome (P =0.002) via increased GRK5 expression. Both T2DM and IGR exhibited its corresponding characteristic symptoms. The variants of GRK5 were involved with both qi-yin deficiency syndrome and dampness-heat encumbering Pi syndrome.

Abstract

GLIS3

GRK5

such as feeling weak in limbs (P =0.0057)

hand tremor (P =0.0208)

bradymasesis (P =0.0234)

and polyuria (P =0.0051). Some of the T2DM patients shared characteristic symptoms

such as desire for cold drinks (P =0.0304)

polyphagia (P =0.0051)

关键词

type 2 diabetes mellitusimpaired glucose regulationChinese Medicinesyndromesgenetic variants

Keywords

type 2 diabetes mellitusimpaired glucose regulationChinese Medicinesyndromesgenetic variants

references

Sun Q, Song K, Shen X, Cai Y. The association between KCNQ1 gene polymorphism and type 2 diabetes risk: a meta-analysis. PLoS One 2012;7:e48578.

Saxena R, Elbers CC, Guo Y, Peter I, Gaunt TR, Mega JL, et al. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet 2012;90:410–425.

Guinan KJ. Worldwide distribution of type II diabetesassociated TCF7L2 SNPs: evidence for stratification in Europe. Biochem Genet 2012;50:159–179.

Potapov VA, Shamkhalova MN, Smetanina SA, Bel’chikova LN, Suplotova LA, Shestakova MV, et al. Polymorphic markers TCF7L2 rs12255372 and SLC30A8 rs13266634 confer susceptibility to type 2 diabetes in a Russian population. Genetika 2010;46:1123–1131.

Dou H, Ma E, Yin L, Jin Y, Wang H. The association between gene polymorphism of TCF7L2 and type 2 diabetes in Chinese Han population: a meta-analysis. PLoS One 2013;8:e59495.

Ohara-Imaizumi M, Yoshida M, Aoyagi K, Saito T, Okamura T, Takenaka H, et al. Deletion of CDKAL1 affects mitochondrial ATP generation and first-phase insulin exocytosis. Plos One 2010;5:e15553.

Kirchhoff K, Machicao F, Haupt A, Schafer SA, Tschritter O, Staiger H, et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008;51:597–601.

Wu Y, Li H, Loos RJ, Yu Z, Ye X, Chen L, et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 2008;57:2834–2842.

Hu C, Zhang R, Wang C, Wang J, Ma X, Lu J, et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One 2009;4:e7643.

Bao XY, Peng B, Yang MS. Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals. Mol Biol Rep 2012;39:2447–2454.

Dupuis J, Langenberg C, Prokopenkol L, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105–116.

Barker A, Sharp SJ, Timpson NJ, Bouatia-Naji N, Warrington NM, Kanoni S, et al. Association of genetic loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children. Diabetes 2011;60:1805–1812.

Kang HS, Kim YS, ZeRuth G, Beak JY, Gerrish K, Kilic G, et al. Transcription factor Glis3, a novel critical player in the regulation of pancreatic beta-cell development and insulin gene expression. Mol Cell Biol 2009;29:6366–6379.

Liu C, Li H, Qi L, Loos RJ, Qi Q, Lu L, et al. Variants in GLIS3 and CRY2 are associated with type 2 diabetes and impaired fasting glucose in Chinese Hans. PLoS One 2011;6:e21464.

Li H, Gan W, Lu L, Dong X, Han X, Hu C, et al. A genomewide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes 2013;62:291–298.

Krilov L, Nguyen A, Miyazaki T, Unson CG, Williams R, Lee NH, et al. Dual mode of glucagon recept or internalization: role of PKC a, GRKs and b-arrestins. Exp Cell Res 2011;317:2981–2994.

Zhuang QZ, Zhao Y, She Y. The study of ancient Xiaoke disease. Chin J Integr Tradit West Med (Chin) 2009;4:612–615.

Wu T. Sun Simiao’s contribution to the treatment of diabetes. J Changchun Univ Tradit Chin Med (Chin) 2011;27:891.

Wang HM, Xue GH, Dan DW. An analysis of ancient Xiaoke disease theory. J Pract Tradit Chin Inter Med (Chin) 2008;22:19–20.

Zheng XY, ed. Guiding principle of clinical research on new drugs of Chinese traditional medicine. Beijing: China Medic-Pharmaceutical Science and Technology Publishing House; 2002.

Ren C, Geng F, Zhang R. Relation between Chinese medicine syndrome and PPARD-87 C > T gene polymorphism in newly diagnosed type 2 diabetes patients. J Tradit Chin Med (Chin) 2012;53:1397–1400.

Tong XL, Dong L, Chen L, Zhen Z. Treatment of diabetes using traditional Chinese medicine: past, present and future. Am J Chin Med 2012;40:877–886.

Dehwah MAS, Wang M, Huang QY. CDKAL1 and type 2 diabetes: a global meta-analysis. Genet Mol Res 2010;9:1109–1120.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36:S67-S74.

Ji L, Li H, Guo X, Li Y, Hu R, Zhu Z. Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial. PloS One 2013;8:e57222.

Maggie B, Covington MD. Traditional Chinese medicine in the treatment of diabetes. Diabetes Spectrum 2001;14:154–159.

Roberts CK, Little JP, Thyfault JP. Modification of insulin sensitivity and glycemic control by activity and exercise. Med Sci Sports Exerc 2013;45:1868–1877.

Wei JP, Zhou LB, Liu F, Zhen Z, Liu YJ. Study of the characteristic of Chinese medicine syndrome of type 2 diabetes. Chin Arch Tradit Chin Med (Chin) 2007;25:2653–2655.

Zhen Z, Chang B, Li M, Lian FM, Chen L, Dong L, et al. Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats. Am J Chin Med 2011;39:53–63.

Sang Z, Zhou L, Fan X, McCrimmon RJ. Radix astragali (Huangqi) as a treatment for defective hypoglycemia counterregulation in diabetes. Am J Chin Med 2010;38:1027–1038.

Wang N, Zhang D, Mao X, Zou F, Jin H, Ouyang J. Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes. Mol Cell Endocrinol 2009;307:89–98.

Chueh WH, Lin JY. Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice. J Agric Food Chem 2011;59:8021–8027.

Yu Y, Liu L, Wang X, Liu X, Liu X, Xie L, et al. Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. Biochem Pharmacol 2010;79:1000–1006.

Xu W, Zhang L, Huang Y, Yang Q, Xiao H, Zhang D. Discrimination of type 2 diabetes mellitus corresponding to different traditional Chinese medicine syndromes based on plasma fatty acid profiles and chemometric methods. J Ethnopharmacol 2012;143:463–468.

He YX, Li X, Wu YY, Wang YM, Luo GA. Gene expression of CDKM2A, CDKN2B, IGF2BP2 and CDKAL1 in diabetic nephropathy patients with CM syndrome differentiations. World Sci Tech/Modern Tradit Chin Med Mater Med (Chin) 2009;11:356–360.

Guo NT, Zhu XH, Lin M. Relation between Chinese medicine syndrome and red blood cell gene expression in type 2 diabetes patients. J Chin Med (Chin) 2004;19:215–216. (Received September 28, 2014; First Online February 26, 2016)

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

A systematic review and meta-analysis of type 2 diabetes mellitus treatment based on the “three-typed syndrome differentiation” theory in Chinese medicine

Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease

Comparison of Aspirin and Naoxintong Capsule (脑心通胶囊) with Adjusted-Dose Warfarin in Elderly Patients with High-Risk of Non-Valvular Atrial Fibrillation and Genetic Variants of Vitamin K Epoxide Reductase

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Related Author

No data

Related Institution

Guang’anmen Hospital, China Academy of Chinese Medical Sciences

Guangdong Research Center of Metabolic Diseases of Integrated Western and Chinese Medicine, Guangdong Pharmaceutical University

Joint Laboratory between Guangdong and Hong Kong on Metabolic Disease, Guangdong Pharmaceutical University

State Key Laboratory of Pharmaceutical Biotechnology, the University of Hong Kong

Department of Internal Medicine, Fujian Provincial Cardiovascular Disease Institute, Provincial Clinical College of Fujian Medical University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰